Condition: Generalized Myasthenia Gravis · Sponsor: Shanghai Jiaolian Drug Research and Development Co., Ltd
The purpose of this study is to evaluate the efficacy and safety of B007 in subjects with generalized myasthenia gravis.
This description comes directly from the study's public registry record.
Jianying Xi · 0086-021-52888045 · hsyybwc@163.com
Huan Yang · 0086-0731-84327919 · xyyyllwyh@126.com
Always discuss trial participation with your own doctor first.
| Peking University First Hospital | Beijing, China | Recruiting |
| The First Bethune Hospital of Jilin University | Changchun, China | Recruiting |
| Xiangya Hospital Central South University | Changsha, China | Recruiting |
| Sichuan Provincial People's Hospital | Chengdu, China | Recruiting |
| Nanfang Hospital, Southern Medical University | Guangzhou, China | Recruiting |
| The First Affiliated Hospital, Zhejiang University School of Medicine | Hangzhou, China | Recruiting |
| Shandong Provincial Qianfoshan Hospital | Jinan, China | Recruiting |
| Shandong University Cheeloo College of Medicine | Jinan, China | Recruiting |
| First People's Hospital of Yunnan Province | Kunming, China | Recruiting |
| Jiangxi Provincial People's Hospital | Nanchang, China | Recruiting |
| The Second Affiliated Hospital of Nanchang University | Nanchang, China | Recruiting |
| Shandong University Cheeloo College of Medicine | Qingdao, China | Recruiting |
+ 6 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06447597